Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | +2.52% |
|
-16.44% | -12.82% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 85.32M | |
+55.97% | 816B | |
+39.34% | 634B | |
-7.48% | 351B | |
+16.50% | 323B | |
+7.44% | 293B | |
+13.26% | 238B | |
+0.90% | 222B | |
+13.40% | 218B | |
+8.03% | 167B |
- Stock Market
- Equities
- CLRB Stock
- News Cellectar Biosciences, Inc.
- Cellectar Biosciences : Oppenheimer Adjusts Cellectar Biosciences' Price Target to $5.50 From $5, Maintains Outperform Rating